Phenotype
|
Fish
|
Conditions
|
Figures
|
trunk epidermis ab1-rps6 labeling amount, ameliorated
|
atp1b1am14/m14 + MO1-st14a
|
hypotonic
|
Fig 3
from Hatzold et al., 2023
|
caudal fin mmp9 expression amount, ameliorated
|
atp1b1am14/m14 + MO1-st14a
|
hypotonic
|
Fig 3
from Hatzold et al., 2023
|
caudal fin cell division frequency, ameliorated
|
atp1b1am14/m14 + MO1-st14a
|
standard conditions
|
Fig 3
from Hatzold et al., 2023
|
pericardium edematous, abnormal
|
atp1b1am14/m14 + MO1-st14a
|
hypotonic
|
Fig 2
from Hatzold et al., 2023
|
pronephric duct ab1-atp1a1 labeling decreased amount, abnormal
|
atp1b1am14/m14 + MO1-st14a
|
hypotonic
|
Fig 2
from Hatzold et al., 2023
|
epidermal basal stratum ab5-akt labeling amount, ameliorated
|
atp1b1am14/m14 + MO1-st14a
|
hypotonic
|
Fig 3
from Hatzold et al., 2023
|
epidermis potentially cancerous lesions amount, ameliorated
|
atp1b1am14/m14 + MO1-st14a
|
standard conditions
|
Fig 1
from Hatzold et al., 2023
|
trunk epidermis ab1-krt labeling decreased amount, abnormal
|
atp1b1am14/m14 + MO1-st14a
|
hypotonic
|
Fig 2
from Hatzold et al., 2023
|
pronephric duct ab1-atp1a1 labeling spatial pattern, abnormal
|
atp1b1am14/m14 + MO1-st14a
|
hypotonic
|
Fig 2
from Hatzold et al., 2023
|
trunk epidermis ab1-krt labeling spatial pattern, abnormal
|
atp1b1am14/m14 + MO1-st14a
|
hypotonic
|
Fig 2
from Hatzold et al., 2023
|
peridermal cell plasma membrane region ab1-llgl2 labeling spatial pattern, abnormal
|
atp1b1am14/m14 + MO1-st14a
|
hypotonic
|
Fig 2
from Hatzold et al., 2023
|
trunk epidermis ab1-rps6 labeling spatial pattern, ameliorated
|
atp1b1am14/m14 + MO1-st14a
|
hypotonic
|
Fig 3
from Hatzold et al., 2023
|
caudal fin mmp9 expression spatial pattern, ameliorated
|
atp1b1am14/m14 + MO1-st14a
|
hypotonic
|
Fig 3
from Hatzold et al., 2023
|
epidermis potentially cancerous lesions increased amount, abnormal
|
clint1ahi1520Tg/hi1520Tg + MO1-st14a
|
standard conditions
|
Fig 1
from Hatzold et al., 2023
|
epidermis potentially cancerous lesions increased amount, abnormal
|
epcamhi2151Tg/hi2151Tg + MO1-st14a
|
standard conditions
|
Fig 1
from Hatzold et al., 2023
|
caudal fin EGFP expression amount, ameliorated
|
sh235Tg/sh235Tg + MO1-st14a + MO2-atp1b1a
|
hypotonic
|
Fig 3
from Hatzold et al., 2023
|
caudal fin EGFP expression spatial pattern, ameliorated
|
sh235Tg/sh235Tg + MO1-st14a + MO2-atp1b1a
|
hypotonic
|
Fig 3
from Hatzold et al., 2023
|
caudal fin epidermal cell aggregated, ameliorated
|
spint1afr26/fr26 + MO1-st14a
|
control
|
Fig. 1
from Armistead et al., 2020
|
epidermis potentially cancerous lesions amount, ameliorated
|
spint1ahi2217Tg/hi2217Tg + MO1-st14a
|
standard conditions
|
Fig 1
from Hatzold et al., 2023
|
whole organism il1b expression amount, ameliorated
|
WT + MO1-spint1a + MO1-st14a
|
standard conditions
|
Fig. 7
from Schepis et al., 2018
|
whole organism mmp9 expression amount, ameliorated
|
WT + MO1-spint1a + MO1-st14a
|
standard conditions
|
Fig. 7
from Schepis et al., 2018
|
epidermal basal stratum cell protruding out of epidermis, ameliorated
|
WT + MO1-spint1a + MO1-st14a
|
control
|
Fig. 5
from Armistead et al., 2020
|
integument cell aggregated, ameliorated
|
WT + MO1-spint1a + MO1-st14a
|
standard conditions
|
Fig. 2
from Schepis et al., 2018
|
whole organism mmp13a.1 expression amount, ameliorated
|
WT + MO1-spint1a + MO1-st14a
|
standard conditions
|
Fig. 7
from Schepis et al., 2018
|
peridermal cell protruding out of epidermis, ameliorated
|
WT + MO1-spint1a + MO1-st14a
|
control
|
Fig. 5
from Armistead et al., 2020
|
caudal fin epidermal cell aggregated, ameliorated
|
WT + MO1-spint1a + MO1-st14a + MO2-itga3b
|
control
|
Fig. 5
from Armistead et al., 2020
|
epidermal basal stratum cell protruding out of epidermis, ameliorated
|
WT + MO1-spint1a + MO1-st14a + MO2-itga3b
|
control
|
Fig. 5
from Armistead et al., 2020
|
peridermal cell protruding out of epidermis, ameliorated
|
WT + MO1-spint1a + MO1-st14a + MO2-itga3b
|
control
|
Fig. 5
from Armistead et al., 2020
|
caudal fin epidermal cell aggregated, ameliorated
|
WT + MO1-spint1a + MO1-st14a + MO3-lama5
|
control
|
Fig. 5
from Armistead et al., 2020
|
epidermal basal stratum cell protruding out of epidermis, ameliorated
|
WT + MO1-spint1a + MO1-st14a + MO3-lama5
|
control
|
Fig. 5
from Armistead et al., 2020
|
peridermal cell protruding out of epidermis, ameliorated
|
WT + MO1-spint1a + MO1-st14a + MO3-lama5
|
control
|
Fig. 5
from Armistead et al., 2020
|
epithelial cell protruding out of epidermal superficial stratum, ameliorated
|
cy22Tg + MO1-spint1a + MO1-st14a
|
standard conditions
|
Fig. 3
from Schepis et al., 2018
|
epidermal superficial stratum cell population proliferation occurrence, ameliorated
|
cy34Tg + MO1-spint1a + MO1-st14a
|
standard conditions
|
Fig. 6
from Schepis et al., 2018
|
epidermal basal stratum cell motility occurrence, ameliorated
|
cy34Tg + MO1-spint1a + MO1-st14a
|
standard conditions
|
Fig. 6
from Schepis et al., 2018
|
epidermal basal stratum cell-cell adhesion process quality, ameliorated
|
la213Tg; mu271Tg + MO1-spint1a + MO1-st14a
|
standard conditions
|
Fig. 4
from Schepis et al., 2018
|
epidermal basal stratum cell motility occurrence, ameliorated
|
la213Tg; mu271Tg + MO1-spint1a + MO1-st14a
|
standard conditions
|
Fig. 4
from Schepis et al., 2018
|
peridermal cell EGFP expression spatial pattern, ameliorated
|
atp1b1am14/m14; fr59Tg/fr59Tg + MO1-st14a
|
hypotonic
|
Fig 6
from Hatzold et al., 2023
|
keratinocyte EGFP expression spatial pattern, ameliorated
|
atp1b1am14/m14; fr59Tg/fr59Tg + MO1-st14a
|
hypotonic
|
Fig 6
from Hatzold et al., 2023
|
epidermal superficial stratum cell population proliferation increased occurrence, ameliorated
|
f2rl1.2sfc18b/sfc18b; cy34Tg + MO1-spint1a + MO1-st14a
|
standard conditions
|
Fig. 6
from Schepis et al., 2018
|
epidermal basal stratum cell motility occurrence, ameliorated
|
f2rl1.2sfc18b/sfc18b; cy34Tg + MO1-spint1a + MO1-st14a
|
standard conditions
|
Fig. 6
from Schepis et al., 2018
|